Evidence of an interaction between <i>FXR1</i> and <i>GSK3β</i> polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics
Antonio Rampino(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Giuseppe Blasi(University of Bari Aldo Moro), Silvia Torretta(University of Bari Aldo Moro), Matteo Iacoviello(University of Bari Aldo Moro), Chiara Magri(University of Pavia), Massimo Gennarelli(Centro San Giovanni di Dio Fatebenefratelli), Antonio Vita(Brescia University), Giulio Pergola(Johns Hopkins University), Aleksandra Marakhovskaya(University of Toronto), Federica Veneziani(University of Bari Aldo Moro), Jean‐Martin Beaulieu(University of Toronto), Leonardo Sportelli(Lieber Institute for Brain Development), Rita Masellis(University of Bari Aldo Moro), Alessandra Minelli(Centro San Giovanni di Dio Fatebenefratelli), Alessandro Bertolino(University of Bari Aldo Moro), Barbara Gelao(University of Bari Aldo Moro), Ileana Andriola(University of Bari Aldo Moro)
Cited by 8
Related Papers
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
|Pharmacological Reviews|2011|2.7k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
|Cell|2005|966
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
|Proceedings of the National Academy of Sciences|2004|786
Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis
|Science|2004|685